These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1726684)

  • 1. Rationale for a combined use of antiretroviral and immunomodulatory therapies in HIV infection.
    Touraine JL; Sanhadji K; Zerhouni B; Livrozet JM
    Int J Immunopharmacol; 1991; 13 Suppl 1():43-8. PubMed ID: 1726684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1.
    Schinazi RF; Cannon DL; Arnold BH; Martino-Saltzman D
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1784-7. PubMed ID: 2469387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine pranobex in the treatment of HIV infection: a review.
    De Simone C; Famularo G; Tzantzoglou S; Moretti S; Jirillo E
    Int J Immunopharmacol; 1991; 13 Suppl 1():19-27. PubMed ID: 1726683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of zidovudine (azidothymidine) with isoprinosine and probenecid in Macaca fascicularis.
    al-Habet SM; Nosbisch C; Williamson T; Tsai CC; Unadkat JD
    Pharm Res; 1994 Jan; 11(1):181-3. PubMed ID: 7511239
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoprinosine stimulates granulocyte chemiluminescence and inhibits monocyte chemiluminescence in vitro.
    Flø RW; Naess A; Albrektsen G; Solberg CO
    APMIS; 1994 Apr; 102(4):249-54. PubMed ID: 7516672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective endocytosis of fluorothymidine and azidothymidine coupled to LDL into HIV infected mononuclear cells.
    Mankertz J; Matthes E; Rokos K; von Baeyer H; Pauli G; Riedel E
    Biochim Biophys Acta; 1996 Dec; 1317(3):233-7. PubMed ID: 8988240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor.
    Staszewski S; Massari FE; Kober A; Göhler R; Durr S; Anderson KW; Schneider CL; Waterbury JA; Bakshi KK; Taylor VI
    J Infect Dis; 1995 May; 171(5):1159-65. PubMed ID: 7538547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
    Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
    N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine.
    Harmenberg J; Akesson-Johansson A; Vrang L; Cox S
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1197-202. PubMed ID: 1701316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group].
    Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
    Ugeskr Laeger; 1994 May; 156(22):3314-8. PubMed ID: 7520643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients.
    De Simone C; Ferrazzi M; Bitonti F; Falciano M; Tzantzoglou S; Delia S; Sorice F
    Immunopharmacol Immunotoxicol; 1988; 10(4):437-41. PubMed ID: 2469710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N; Ormrod D; Perry CM; Figgitt DP
    Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.
    Larder BA; Kemp SD; Harrigan PR
    Science; 1995 Aug; 269(5224):696-9. PubMed ID: 7542804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.
    Foudraine NA; de Jong JJ; Jan Weverling G; van Benthem BH; Maas J; Keet IP; Jurriaans S; Roos MT; Vandermeulen K; de Wolf F; Lange JM
    AIDS; 1998 Aug; 12(12):1513-9. PubMed ID: 9727573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antiviral effect in vitro of azidothymidine and amphotericin B methyl ester in combination on HIV infection.
    Hansen JE; Nielsen C; Svenningsen A; Witzke N; Mathiesen LR
    Scand J Infect Dis; 1992; 24(1):35-9. PubMed ID: 1589723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
    JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro antiviral activity of isoprinosine on simian rotavirus (SA-11).
    Linhares RE; Wigg MD; Lagrota MH; Nozawa CM
    Braz J Med Biol Res; 1989; 22(9):1095-103. PubMed ID: 2483980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.
    Pellegrin I; Izopet J; Reynes J; Denayrolles M; Montes B; Pellegrin JL; Massip P; Puel J; Fleury H; Segondy M
    AIDS; 1999 Sep; 13(13):1705-9. PubMed ID: 10509572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.